ClinicalTrials.gov
public full text
Public Domain
Single Ascending Dose Study of RBP-6000
A multi-center, open-label, single ascending dose study to enroll opioid dependent treatment-seeking subjects. Subjects to be enrolled into 3 cohorts receiving low, medium and high doses of depot buprenorphine. A fourth cohort will be enrolled to evaluate the PK of RBP-6000 after receiving suboxone tablets for 7 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome#876804
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1#874018
- Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder.#247656
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3#994775
- Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol#1152726
Record · ID 884075
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive